Dow Up0.36% Nasdaq Up0.16%

BioMarin Pharmaceutical Inc. (BMRN)

-NasdaqGS
79.62 Up 4.61(6.15%) 1:15PM EDT - Nasdaq Real Time Price
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Total Revenue 548,485   500,723   441,358  
Cost of Revenue95,742  91,830  84,023  
Gross Profit 452,743   408,893   357,335  
Operating Expenses
Research Development354,780  302,218  214,374  
Selling General and Administrative235,356  198,173  175,423  
Non Recurring -   -   -  
Others18,614  18,717  1,428  
Total Operating Expenses -   -   -  
Operating Income or Loss (156,007) (110,215) (33,890)
Income from Continuing Operations
Total Other Income/Expenses Net(8,900)797  1,098  
Earnings Before Interest And Taxes(166,056)(110,639)(35,218)
Interest Expense10,447  7,639  8,409  
Income Before Tax(176,503)(118,278)(43,627)
Income Tax Expense(150)(3,931)10,209  
Minority Interest -   -   -  
Net Income From Continuing Ops(177,502)(115,568)(56,262)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (176,353) (114,347) (53,836)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares (176,353) (114,347) (53,836)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.